Triapine (3-AP) / Vion, Northwestern University |
NCT00078975: 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer |
|
|
| Completed | 2 | 26 | Canada | gemcitabine hydrochloride, triapine | University Health Network, Toronto, National Cancer Institute (NCI) | Pancreatic Cancer | 12/05 | 01/09 | | |
NCT00085371: Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas |
|
|
| Completed | 2 | 116 | US | triapine | National Cancer Institute (NCI) | Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer | 07/06 | | | |
NCT00064051: 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer |
|
|
| Completed | 2 | | US, Europe | gemcitabine hydrochloride, triapine | Vion Pharmaceuticals | Pancreatic Cancer | 08/06 | 08/08 | | |
NCT00077545: 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction |
|
|
| Completed | 2 | 39 | US | triapine, cisplatin | National Cancer Institute (NCI) | Adenocarcinoma of the Esophagus, Recurrent Esophageal Cancer, Stage IV Esophageal Cancer | 03/07 | | | |
NCT00075504: Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer |
|
|
| Completed | 2 | 33 | US | triapine, 3-AP, OCX-191, gemcitabine, dFdC, difluorodeoxycytidine hydrochloride, Gemzar | National Cancer Institute (NCI) | Stage II Gallbladder Cancer, Stage IIIA Gallbladder Cancer, Stage IIIB Gallbladder Cancer, Stage IVA Gallbladder Cancer, Stage IVB Gallbladder Cancer | 01/09 | 01/09 | | |